Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Bertolini

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Clinical Chemistry|March 19, 2022
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and SarcomaMarta Vismara, Carolina Reduzzi, Marco Silvestri, et al.
Molecular Oncology|June 9, 2021
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingDaniela Di Paolo, Francesca Pontis, Massimo Moro, et al.
Cancer Research|July 5, 2015
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor PrognosisGiulia Bertolini, Lucia D'Amico, Massimo Moro, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cellsMonica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentGiulia Bertolini, Luca Roz, Paola Perego, et al.
Cancer Letters|March 8, 2021
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescenceMarta Gabasa, Evette S Radisky, Rafael Ikemori, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cellsMaria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2021
A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancerGiulia Bertolini, Valeria Cancila, Massimo Milione, et al.
Heliyon|August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterizationLuigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.
Plos One|May 8, 2020
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with SorafenibFrancesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Chemistry|March 19, 2022
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and SarcomaMarta Vismara, Carolina Reduzzi, Marco Silvestri, et al.
Molecular Oncology|June 9, 2021
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingDaniela Di Paolo, Francesca Pontis, Massimo Moro, et al.
Cancer Research|July 5, 2015
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor PrognosisGiulia Bertolini, Lucia D'Amico, Massimo Moro, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cellsMonica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatmentGiulia Bertolini, Luca Roz, Paola Perego, et al.
Cancer Letters|March 8, 2021
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescenceMarta Gabasa, Evette S Radisky, Rafael Ikemori, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
CD56<sup>bright</sup> cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cellsMaria L Guevara Lopez, Ann Gebo, Monica Parodi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2021
A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancerGiulia Bertolini, Valeria Cancila, Massimo Milione, et al.
Heliyon|August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterizationLuigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.
Plos One|May 8, 2020
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with SorafenibFrancesco Caputo, Vincenzo Dadduzio, Francesco Tovoli, et al.
Pageof 5